UK clinical trials currently recruiting patients. Find trials for your condition and talk to your doctor about whether you're eligible.
⚕️ Important: Always speak to your doctor before applying to any clinical trial. Never stop existing treatment without medical advice.
The LOLIPOP Trial is a large (n=4,300 patients) pragmatic, international, multicentre, prospective, randomised, double blind, placebo-controlled, parallel assessment, safety and effectiveness superiority study.
Run by: Monash University
The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic…
Run by: Michael J. Fox Foundation for Parkinson's Research
Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advanced or recurrent. * EC is…
Run by: Merck Sharp & Dohme LLC
The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS). The primary…
Run by: Merck Sharp & Dohme LLC
Researchers want to know if sacituzumab tirumotecan given alone or with pembrolizumab can treat triple negative breast cancer (TNBC). The main goal of this study…
Run by: Merck Sharp & Dohme LLC
Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer may have a higher…
Run by: Merck Sharp & Dohme LLC
The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-free longer than people who receive…
Run by: Merck Sharp & Dohme LLC
The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The study duration including screening…
Run by: Eli Lilly and Company
The main purpose of this study is to evaluate the safety of LY3954068 in participants with early symptomatic Alzheimer's Disease (AD). The study will also…
Run by: Eli Lilly and Company
Researchers want to know if the study treatment called MK-2214 works to slow certain changes in the brains of people with Alzheimer's disease (AD). AD…
Run by: Merck Sharp & Dohme LLC